Adam I. Riker, MD

Articles by Adam I. Riker, MD

Treatment Options for Patients with Stage III & IV Melanoma: Part II: Experimental treatments for stage III/IV or refractory/recurrent melanoma

ByAdam I. Riker, MD,Paul M. Howell, BS

March 12th 2011

Various immunotherapeutic strategies to treat advanced melanoma have been under investigation for more than a decade

Resection and Reconstruction of a Solitary Sternal Metastasis After Mastectomy for Breast Cancer: A Case Report and Review of the Literature

ByRamona Hagmaier, MHS, PA-C,Hung T. Khong, MD,Carl Maltese, MD,Randy D. Proffitt, MD,Adam I. Riker, MD

March 3rd 2011

In May 2005, a 25-year-old female presented to her primary care physician complaining of a newly palpable breast mass that had grown to several centimeters over the course of a few months.

Adam I. Riker, MD

Articles by Adam I. Riker, MD

Treatment Options for Patients with Stage III & IV Melanoma: Part II: Experimental treatments for stage III/IV or refractory/recurrent melanoma

Resection and Reconstruction of a Solitary Sternal Metastasis After Mastectomy for Breast Cancer: A Case Report and Review of the Literature

Latest Updated Articles

Trending on OncLive

Domvanalimab/Zimberelimab Plus Chemotherapy Fails to Improve OS in HER2-Negative Gastroesophageal Adenocarcinoma

Extended FOLFOX, Atezolizumab Duration Linked With Improved DFS in Stage III dMMR Colon Cancer

ctDNA MRD Status Predicts OS Benefit With Adjuvant Chemotherapy in Resected CRC Liver Metastases

How Bispecific T-Cell Engager Therapy Works and Why HLA Status Is Non-Negotiable

Neoadjuvant/Adjuvant Pembrolizumab Yields EFS Benefits Regardless of Surgical Outcomes in HNSCC